Sanofi acquired Vicebio Ltd to expand its vaccine design capabilities.
1 report, 1 independent
Updated Jul 23
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Sanofi acquired Vicebio Ltd to expand its vaccine design capabilities.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Sanofi
company in Milan, Italy
Nothing else this week.
Coverage
Newest first; wire copies grouped- BenzingaSanofi Expands Respiratory Vaccine Portfolio With UK Biotech Buy Sanofi SA (NASDAQ:SNY) on Tuesday agreed to acquire Vicebio Ltd, a privately held biotechnology company headquartered in London, U.K.